来自 Fabaceae 的前化异黄,用于抵抗 Staphylococcus aureus 中的 NorA 排泄
Marina Ika Irianti1,2, Jean-Paul Vincken1, Sarah van Dinteren1
1Laboratory of Food Chemistry, Wageningen University and Research, Bornse Weilanden 9, 6708 WG, Wageningen, The Netherlands.
Scientific reports
|December 18, 2023
概括
来自豆类的前化异黄,如新和玻璃烯,抑制了S. aureus中的NORA排泄. 这些化合物增强诺基诺对抗耐药菌株的有效性,没有显著的毒性.
科学领域:
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
背景情况:
- 诺拉的排水有助于 Staphylococcus aureus 的多药性耐药性.
- 诺基诺耐药性是一个日益严重的公共卫生问题.
- 自然化合物为抗微生物药物开发提供了潜在的替代品.
研究的目的:
- 调查前化异黄作为潜在的排泄抑制剂 (EPI) 对抗诺基诺耐药的黄金色杆菌.
- 为了识别抑制NORA排泄的特定的化异黄.
- 评估这些化合物作为抗性修饰剂的疗效和安全性.
主要方法:
- 选前化异黄的排泄抑制活性.
- 在NorA中评估乙积累,以评估过度表达黄金色杆菌.
- 确定化合物对诺基诺隆最小抑制度 (MIC) 的影响.
- 在Caco-2细胞中评估细胞毒性和膜透性.
主要成果:
- 四种先化异类黄,包括新化异和格拉布伦,证明了NORA排泄的抑制.
- 新巴瓦伊索弗拉和格拉布伦显著增加了乙积累,并提高了诺基诺MICs.
- 活动被证实是NORA依赖的,因为在NORA淘汰菌株中没有发现增强.
- 新巴瓦伊索弗拉的疗效与保留素相比或更高,细胞毒性较低.
结论:
- 化异黄,特别是新异黄和格拉布伦,是S. aureus中NORA排泄的有效抑制剂.
- 这些植物化学物质显示出作为抗微生物剂和抵抗修饰剂的承诺,用于对抗抗诺基诺耐药的黄金色菌.
- 新巴瓦伊索弗拉和格拉布伦具有良好的安全性,没有观察到哺乳动物细胞中细胞毒性或膜破坏.
更多相关视频
06:36Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
2.8K
09:50Biosynthesis of a Flavonol from a Flavanone by Establishing a One-pot Bienzymatic Cascade
Published on: August 14, 2019
9.4K
相关概念视频
Antimicrobial Proteins
1000
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
1000
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
